Read + Share
Chakraborty S, Utter MB, Frias MA, Foster DA, et al. Cancer cells with defective RB and CDKN2A are resistant to the apoptotic effects
of rapamycin. Cancer Lett 2021;522:164-170.
PMID: 34563639
|
 |
|
Chakraborty S, Utter MB, Frias MA, Foster DA, et al. Cancer cells with defective RB and CDKN2A are resistant to the apoptotic effects
of rapamycin. Cancer Lett 2021;522:164-170.
PMID: 34563639
|
|
|
|